Clinical Updates on Lung Cancer Approaches

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".

Deadline for manuscript submissions: 25 January 2025 | Viewed by 48

Special Issue Editor


E-Mail Website
Guest Editor
1. Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK
2. Department of Oncology, University of Oxford, Oxford OX1 2JD, UK
3. Discipline of Medical Oncology, Post-Graduation Programme in Medicine, Faculty of Medicine, Nine of July University (UNINOVE), São Paulo 04101-000, Brazil
Interests: medical oncology; immunotherapy; biomarkers; EGFR insertion 20; MET inhibitors; ALK inhibitors; target therapies; lung cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Lung cancer is a challenging disease worldwide. Currently, recent advances regarding biomarkers and systemic therapies have been developed to alter this disease’s prognosis. Broad NGS panels are now a reality in clinical practice; they help a lot of clinicians in making the best decisions to ultimately improve patient care. In this Special Issue, we hope to examine papers regarding innovation and novel technologies for lung cancer diagnosis and treatment. We welcome original articles, meta-analyses, systematic reviews, narrative reviews, clinical cases, and clinical trials regarding lung cancer issues.

Prof. Dr. Ramon Andrade De Mello
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted therapies
  • immunotherapy
  • biomarkers
  • lung cancer
  • thoracic oncology

Published Papers

This special issue is now open for submission.
Back to TopTop